Home/Pipeline/Cerebro Platform for cSDH

Cerebro Platform for cSDH

Chronic Subdural Hematoma

Pre-clinicalActive

Key Facts

Indication
Chronic Subdural Hematoma
Phase
Pre-clinical
Status
Active
Company

About Vonova.io

Vonova is pioneering a transvascular platform to revolutionize brain access by using the venous system, thereby avoiding the risks and invasiveness of traditional craniotomy. Founded in 2020 and based in San Francisco, the company's 'Cerebro Platform' is a guided neurovascular system designed to improve recovery times and expand treatment options for millions of patients with chronic neurological disorders. Having secured seed financing and recognition as a MedTech Innovator finalist, Vonova is positioned at the intersection of neuroscience and advanced device technology to address a significant unmet clinical need.

View full company profile